首站-论文投稿智能助手
典型文献
Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal melanoma
文献摘要:
More than 85%of patients with uveal melanoma(UM)carry a GNAQ or GNA11 mutation at a hotspot codon(Q209)that encodes G protein α subunit q/11 polypeptides(Gαq/11).GNAQ/11 relies on palmitoylation for membrane association and signal transduction.Despite the palmitoylation of GNAQ/11 was discovered long before,its implication in UM remains unclear.Here,results of palmitoylation-targeted mutagenesis and chemical interference approaches revealed that the loss of GNAQ/11 palmitoylation substantially affected tumor cell proliferation and survival in UM cells.Palmitoylation inhibition through the mutation of palmitoylation sites suppressed GNAQ/11QQ209L-induced malignant transformation in NIH3T3 cells.Importantly,the palmitoylation-deficient oncogenic GNAQ/11 failed to rescue the cell death initiated by the knock down of endogenous GNAQ/11 oncogenes in UM cells,which are much more dependent on Goq/11 signaling for cell survival and proliferation than other melanoma cells without GNAQ/11 mutations.Furthermore,the palmitoylation inhibitor,2-bromopalmitate,also specifically disrupted Gaq/11 downstream signaling by interfering with the MAPK pathway and BCL2 survival pathway in GNAQ/1 1-mutant UM cells and showed a notable synergistic effect when applied in combination with the BCL2 inhibitor,ABT-199,in vitro.The findings validate that GNAQ/11 palmitoylation plays a critical role in UM and may serve as a promising therapeutic target for GNAQ/11-driven UM.
文献关键词:
作者姓名:
Yan Zhang;Baoyuan Zhang;Yongyun Li;Yuting Dai;Jiaoyang Li;Donghe Li;Zhizhou Xia;Jianming Zhang;Ping Liu;Ming Chen;Bo Jiao;Ruibao Ren
作者机构:
Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Collaborative Innovation Center of Hematology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Department of Ophthalmology,Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology,Shanghai 200001,China;Department of Biology,Brandeis University,Waltham,MA 02454,USA
文献出处:
引用格式:
[1]Yan Zhang;Baoyuan Zhang;Yongyun Li;Yuting Dai;Jiaoyang Li;Donghe Li;Zhizhou Xia;Jianming Zhang;Ping Liu;Ming Chen;Bo Jiao;Ruibao Ren-.Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal melanoma)[J].医学前沿,2022(05):784-798
A类:
Palmitoylation,GNA11,Q209,palmitoylation,11QQ209L,Goq,bromopalmitate,Gaq
B类:
GNAQ,critical,tumor,proliferation,survival,mutant,uveal,melanoma,More,than,patients,UM,carry,hotspot,codon,that,encodes,protein,subunit,polypeptides,relies,membrane,association,transduction,Despite,was,discovered,long,before,its,implication,remains,unclear,Here,results,targeted,mutagenesis,chemical,interference,approaches,revealed,loss,substantially,affected,cells,inhibition,through,sites,suppressed,induced,malignant,transformation,NIH3T3,Importantly,deficient,oncogenic,failed,rescue,death,initiated,by,knock,endogenous,oncogenes,which,are,much,dependent,signaling,other,without,mutations,Furthermore,inhibitor,also,specifically,disrupted,downstream,interfering,MAPK,pathway,BCL2,showed,notable,synergistic,effect,when,applied,combination,ABT,vitro,findings,validate,plays,role,may,serve,promising,therapeutic,driven
AB值:
0.479951
相似文献
CircRNA.0007127 triggers apoptosis through the miR-513a-5p/CASP8 axis in K-562 cells
Xiajing LI;Yiyu ZHANG;Ning WANG;Zhaohu YUAN;Xiaojie CHEN;Qicong CHEN;Hui DENG;Xinxin TONG;Honglin CHEN;Yuyou DUAN;Yarning WEI-School of Medicine,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,Shenzhen Longhua Central Hospital,Shenzhen 518000,China;Laboratory of Stem Cells and Translational Medicine,Institutes for Life Sciences,School of Medicine,South China University of Technology,Guangzhou 510000,China;School of Biomedical Sciences and Engineering,Guangzhou International Campus,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,the Second Affiliation Hospital of South China University of Technology,Guangzhou 510000,China;Guangdong Engineering Research Center of Precise Transfusion,Guangzhou 510000,China
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma
Rongfang Wei;Xing Cui;Jie Min;Zigen Lin;Yanyan Zhou;Mengjie Guo;Xiaojuan An;Hao Liu;Siegfried Janz;Chunyan Gu;Hongbo Wang;Ye Yang-Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,Nanjing 210022,China;School of Medicine&Holistic Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China;Department of Hematology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,China;Division of Hematology and Oncology,Medical College of Wisconsin,Milwaukee,WI 53226,USA;School of Pharmacy,Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Yantai University,Yantai 264005,China;Bohai Rim Advanced Research Institute for Drug Discovery,Yantai 264003,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。